Community/Retail

Study findings provide insight into factors preventing the uptake of pre-exposure prophylaxis for HIV among Black female adolescents and emerging adults and provide potential strategies to improve uptake.

The study also found that joint hypermobility was more common in females than in males.

Although quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.

A deficiency in the supplement is thought to be associated with early activation of the hypothalamic-pituitary gonadal axis, obesity, and stunting.

Findings suggest that the children benefitted from the CBT-based program when delivered in a shorter format.

While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.

New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.

By leveraging do-it-yourself testing momentum, community-based and retail pharmacies can solidify their position as health care hubs with a category management approach that enhances the consumer experience and boosts store relevance and revenue.

The updated recommendations during a surge in cases emphasize the need to enhance emergency readiness daily to not interrupt continuous care of children’s mental and physical well-being.

Despite the increasing approval of neurological medications, just a small percentage of individuals are using them because of skyrocketing out-of-pocket expenses.

Study finds gluten-free diets may play an important role in the causality of celiac disease on the development of psoriasis.

When mildly ill, individuals who reflect on the potential consequences of their behavior are less likely to go to holiday gatherings and events.

It is important that our national and even state and local professional pharmacy organizations are coming together as a voice for the profession.

Although progress has been made in pre-exposure prophylaxis use, there are still significant barriers for many patients.

Investing in outpatient behavioral health treatment pathways found to be a cost-effective measure to better manage both medical and behavioral conditions.

Although the evidence suggested some deterioration for a few aspects of mental health, the overall findings were mixed with no clear pattern.

The American Heart Association said that yoga, tai-chi, and certain alternative medicines may be beneficial for heart failure, whereas other products may be harmful.

Respiratory syncytial virus- and rhinovirus-induced wheezing illnesses differ from each other at multiple levels.

Prior research indicates a platelet-based connection between migraine and the patent foramen ovale.

Relatives who attend low-intensity coaching and monitoring meetings increase individuals’ ability to manage the disease.

Following the approval of cabotegravir in 2021, governments and donor agencies in low- and middle-income countries are contemplating replacing oral pre-exposure prophylaxis or augmenting the approach with long-acting treatment.

Herpes zoster and postherpetic neuralgia can cause a significant health burden among adults 65 years of age and older.

Dapagliflozin (Farxiga) found effective in lowering the risk of hospitalization for patients with chronic kidney disease, with or without a diagnosis of type 2 diabetes, and increased the number of days alive and out of the hospital.

Lead compounds may lower the risk of abuse and other adverse effects compared with other drugs currently being evaluated for mental health disorders, such as MDMA.

The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.

Palivizumab is a humanized monoclonal antibody approved by the FDA to prevent serious lower respiratory tract infection caused by respiratory syncytial virus in infants and young children.

Zavegepant could become the first intranasal drug that targets CGRP in migraine sufferers to gain FDA approval.

Atrasentan has been found to lower albuminuria, which correlates with reductions in low-density lipoprotein cholesterol and triglycerides.

Booster shots updated for the Omicron variant BA.4 and BA.5 lineages cleared for children 6 months through 4 years of age.

A modified secukinumab dosing regimen produced outcomes on par with currently recommended intervals in patients with moderate-to-severe psoriasis, but longer follow-ups are needed to confirm the findings.